Logo

Sign in | Create an Account Cart 0
Sign In
Forgot password?
Institutional Users can Sign In here
Don't have an Account?
Create an account
 
Forgot Password
 
Thank You for Registration

Thank-you for creating an account on Longwoods.com.

As a registered user of longwoods.com you can receive the following benefits:
  • Abstracts from ALL Longwoods.com publications
  • Citation tracking and reference links to full-text articles
  • Ability to share the information through various social media outlets with a single click
  • Ability to comment on any article
  • Pay-per-View purchases of single articles or issues by credit card or paypal
  • Choice of any www.longwoods.com/newsletters delivered to your email inbox for free
  • Ability to sign up for any www.longwoods.com/events.
  • The advantage of having password access to www.Longwoods.com from any computer anywhere
Please check your e-mail and follow the instructions to activate your account. If you do not receive an e-mail, please check your junk folder.
Reset Password

Please check your e-mail and follow the instructions to reset your password.

Menu
  • Home
  • Topics
    • Access to Care
    • Aging
    • Alternative Levels of Care
    • Caregivers
    • Change Management
    • Community Care
    • COVID-19
    • Decision Making
    • Digital Health
    • Effective Teamwork
    • Equity in Healthcare
    • Governance
    • Health Human Resources
    • Health System Innovation
    • Healthcare Costs
    • Healthcare Policy
    • Healthy workplaces
    • Home Care
    • Innovations in Care
    • Leadership Development
    • Long-Term Care
    • Longwoods Healthcare Services Radio
    • Mental Health
    • Nursing Leadership
    • Pandemic Planning
    • Patient Experience
    • Patient Safety
    • Patient-Centered Care
    • Primary Care
    • Public Health
    • Quality Improvement
    • System Integration
    • Workforce Planning
  • Events
    • Longwoods Breakfast Series
    • Healthcare Rounds
    • Leadership Discussion
    • Conferences and Education
    • Healthcare Awards
  • Publications
    • Healthcare Quarterly
    • HealthcarePapers
    • Healthcare Policy
    • Nursing Leadership
    • Insights
    • Special Issues
    • White Papers
    • Longwoods Blog
    • World Health & Population
    • ElectronicHealthcare
    • Law & Governance
    • Books
  • Multimedia
    • Videos
    • Podcasts
  • Jobs
    • Longwoods Job Site
    • HR Resources Database
    • Transitions
    • Rates for Job Postings
  • Subscribe

Health & Healthcare News

UofT: Potential Genetic Cause of Severe Sleep Disorder Discovered, Implications for Parkinson’s Disease Research

TORONTO, ON – Researchers at the University of Toronto are the first to indentify a potential cause for a severe sleep disorder that has been closely linked to Parkinson’s disease and other neurodegenerative diseases.

“Our research is the first to establish a potential genetic link to human REM sleep behaviour disorder (RBD).  That’s important because between 60 and 80 per cent of people diagnosed with human RBD develop Parkinson’s disease or other neurodegenerative disorders later in life,” says Dr. John Peever, lead author of the study that recently appeared in The Journal of Neuroscience.

Rapid-eye-movement sleep behaviour disorder (RBD) is most often characterized by violent movements that occur during dreaming sleep, also called rapid-eye-movement sleep.  People who suffer from RBD do not experience normal muscle paralysis that prevents them from enacting their dreams and they often hurt themselves or their bed partners with their rapid, forceful movements. In some cases, patients need to be tied to their bed to prevent serious injury to themselves or their bedpartners.

Peever’s team focused on investigating a genetic cause of RBD because the underlying cause of this disorder is unknown. There is evidence indicating that reduced brain inhibition could cause RBD, so Peever’s team genetically reduced brain inhibition in mice and then recorded their sleep and muscle activity.

“We found that mice with reduced brain inhibition acted just like human RBD patients and they moved violently during REM sleep,” says Peever. “This link strongly suggests that patients with RBD may also have impaired brain inhibition.” 

They also found that RBD symptoms in mice could be alleviated by giving them clonazepam – a drug used to treat human RBD.
Peever’s research underscores the importance of identifying a cause of RBD as 60 – 80 per cent of RBD sufferers subsequently develop Parkinson’s.

“Treating RBD could have direct implications for understanding and perhaps treating Parkinson’s disease,” says Peever.

-30-

For more information, please contact:

John Peever
Associate Professor
Department of Cell and Systems Biology
Work: 416-946-5564
Cell: 647-207-7920
john.peever@utoronto.ca

Contact information

Contact Us
Mailing address

260 Adelaide Street East, No. 8, Toronto ON M5A 1N1

Telephone number
416-864-9667
Fax number
416-368-4443

Subscribe Today

  • Healthcare Quarterly

    Best practices, policy and innovations in the administration of healthcare 

Stay Connected

Newsletter
© 2026
Longwoods Publishing Corporation
  • Institutional Users
  • About Us
  • Subscription Information
  • Advertise
  • Reprints
  • Partners
  • Terms
  • Privacy